Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces NIH’s transition-related terminology updates above the study page, which continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:55:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T20:32:23.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T20:50:39.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    No additions or deletions were reported for this page in the provided data.
    Difference
    0.2%
    Check dated 2026-09-26T20:40:46.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study content. This indicates an access or server issue and the study details are unavailable on this page.
    Difference
    19%
    Check dated 2026-09-19T19:22:02.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6, replacing v3.6.5. This reflects a site maintenance update rather than substantive changes to study content.
    Difference
    0.1%
    Check dated 2026-08-29T20:07:56.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.